Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

5:31 mins

Elena Sturman, The Glaucoma Foundation: Presidential Update 2022

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 21st 2022

The Glaucoma Foundation is dedicated to developing a cure for glaucoma through innovative research, collaboration and education. Its goal is to eradicate blindness caused by glaucoma. The Foundation works to encourage and support basic and applied research in glaucoma with a goal of preserving and restoring vision. The Glaucoma Foundation strives to be an important resource to help patients, their families, and at-risk individuals to manage their glaucoma through education and outreach.

 

touchOPHTHALMOLOGY caught up with the President of The Glaucoma Foundation, Elena Sturman, to discuss the objectives of the Foundation in 2022, research priorities and some exciting upcoming events.

For more information, please visit: https://glaucomafoundation.org/

Questions:

  1. What are the objectives of The Glaucoma Foundation (TGF)?
  2. What are the major challenges faced by the glaucoma community at the moment?
  3. What are the TGF’s research priorities for the coming year?
  4. Could you tell us a little about the TGF’s recent and upcoming events?
  5. Of what achievements are you most proud in your role as President?

Disclosures: Elena Sturman has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Lisa Glass.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup